|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total cash and cash equivalents (note 3) | ||||||||||||||||||||
| Securities (note 4): | ||||||||||||||||||||
| Trading debt securities, at fair value | ||||||||||||||||||||
| Debt securities held-to-maturity, at amortized cost (fair value of $4.02 billion and $3.78 billion) | ||||||||||||||||||||
| Debt securities held-to-maturity, at amortized cost and net of allowance for credit losses of $1.6 million at both dates (fair value of $4.24 billion and $4.27 billion) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Debt securities available-for-sale, at fair value | ||||||||||||||||||||
| Debt securities held-to-maturity, at amortized cost and net of allowance for credit losses of $1.5 million and $1.6 million (fair value of $4.04 billion and $4.27 billion) | ||||||||||||||||||||
| Federal Reserve Bank and Federal Home Loan Bank stock, at cost | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||||
| Loans held-for-sale (note 5) | ||||||||||||||||||||
| Commercial and Industrial | ||||||||||||||||||||
| Total loans held-for-sale (note 5) | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Retail Loans | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less allowance for credit losses on loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Retail Loans | ||||||||||||||||||||
| Total less allowance for credit losses on loans | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Loans (notes 5, 6 and 7): | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Retail Loans | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less allowance for credit losses on loans | ||||||||||||||||||||
| Commercial | ||||||||||||||||||||
| Retail Loans | ||||||||||||||||||||
| Total less allowance for credit losses on loans | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Goodwill (notes 2 and 8) | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Premises and equipment, net (note 9) | ||||||||||||||||||||
| Other acquisition-related intangible assets (notes 2 and 8) | ||||||||||||||||||||
| Other assets (notes 4, 5, 7, 10 and 23) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits (note 11): | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Interest-bearing checking and money market | ||||||||||||||||||||
| Time | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings (note 12): | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Customer repurchase agreements | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| Total borrowings | ||||||||||||||||||||
| Notes and debentures (note 13) | ||||||||||||||||||||
| Other liabilities (notes 7, 10 and 23) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity (notes 2, 15, 18, 19 and 20): | ||||||||||||||||||||
| Preferred stock ($0.01 par value; 50.0 million shares authorized; 10.0 million shares issued and outstanding at both dates) | ||||||||||||||||||||
| Common stock ($0.01 par value; 1.95 billion shares authorized; 536.9 million shares and 533.7 million shares issued) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Unallocated common stock of Employee Stock Ownership Plan, at cost (5.2 million shares and 5.6 million shares) | ||||||||||||||||||||
| Treasury stock, at cost (109.0 million shares at both dates) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...